Microbix Biosystems Inc. (MBX)

Toronto


	Symbol		Exchange		Currency
	MBX		Toronto		CAD	Real-time
	MBXBF		OTC Markets		USD	Delayed

Currency in CAD

Disclaimer

0.34

-0.01(-2.94%)

Closed11/10

Fair Value

Day's Range

0.33

0.34

52 wk Range

0.23

0.45

MBX Income Statement

Featured here, the Income Statement (earnings report) for Microbix Biosystems Inc., showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2014

30/09

2015

30/09

2016

30/09

2017

30/09

2018

30/09

2019

30/09

2020

30/09

2021

30/09

2022

30/09

2023

30/09

Total Revenues

13.41

10.52

18.59

19.08

16.51

Total Revenues Growth

+7.21%

-21.53%

+76.66%

+2.6%

-13.43%

Cost Of Revenues

6.86

5.86

7.55

7.95

9.03

Gross Profit

6.55

4.66

11.04

11.12

7.48

Gross Profit Growth

+21.94%

-28.81%

+136.95%

+0.73%

-32.75%

Gross Profit Margin %

48.82%

44.28%

59.4%

58.32%

45.3%

Other Operating Expenses, Total

5.44

5.19

6.21

8.51

10.22

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+3.37%	-4.64%	+19.71%	+37.17%	+20%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	1.04	1.01	1.03	1.8	2.05
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	4.4	4.17	5.17	6.72	8.17
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

1.11

-0.52

4.84

2.61

-2.74

Operating Income Growth

+917.67%

-147.27%

+1,021.96%

-46.03%

-204.84%

EBIT Margin %

8.27%

-4.98%

26.01%

13.68%

-16.57%

Net Interest Expenses

-1.07

-1.06

-1.6

-0.74

-0.38

Net Interest Expenses Growth

-25.15%

+0.94%

-51.8%

+53.57%

+48.72%

Interest Expense, Total

-1.07

-1.06

-1.6

-0.83

-0.84

Interest And Investment Income

-

-

0

0.08

0.46

Other Non Operating Expenses, Total

-

-

-

-

-

EBT, Excl. Unusual Items

0.04

-1.58

3.23

1.87

-3.12

Gain (Loss) On Sale Of Assets

-

-

-

-

-

Other Unusual Items, Total

-

-3.08

-

-

3.08

EBT, Incl. Unusual Items

0.04

-4.66

3.23

1.87

-0.04

EBT, Incl. Unusual Items Growth

+100.51%

-10,766.62%

+169.4%

-42.29%

-102.12%

EBT, Incl. Unusual Items Margin

0.33%

-44.27%

17.39%

9.78%

-0.24%

Income Tax Expense

0.01

1.57

-

0.08

-

Net Income to Company

0.03

-6.23

3.23

1.79

-0.04

Minority Interest

-

-

-

-

-

Net Income

0.03

-6.23

3.23

1.79

-0.04

Net Income Growth

+100.37%

-19,611.01%

+151.92%

-44.68%

-102.21%

Net Income Margin %

0.24%

-59.17%

17.39%

9.38%

-0.24%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

0.03

-6.23

3.23

1.79

-0.04

Basic EPS - Continuing Operations

0

-0.06

0.03

0.01

-0

Basic EPS - Continuing Operations Growth

+100.37%

-18,154.71%

+147.4%

-53.07%

-102.16%

Diluted EPS - Continuing Operations

0

-0.06

0.03

0.01

-0

Diluted EPS - Continuing Operations Growth

+100.36%

-18,209.76%

+143.75%

-49.98%

-102.2%

Basic Weighted Average Shares Outstanding

96.97

104.84

114.85

135.38

137.91

Diluted Weighted Average Shares Outstanding

97.09

104.84

141.68

141.69

137.91

Dividend Per Share

-

-

-

-

-

Dividend Per Share Growth

-

-

-

-

-

EBITDA

1.54

-0.1

5.39

3.33

-1.9

EBITDA Growth

+133.61%

-106.2%

+5,744.04%

-38.21%

-156.97%

EBITDA Margin %

11.48%

-0.91%

28.97%

17.45%

-11.48%

EBIT